Ethanol withdrawal mitigates fatty liver by normalizing lipid catabolism

Area of Science:

• Hepatology
• Cellular Biology
• Metabolic Research

Background:

• Chronic ethanol (EtOH) consumption leads to alcohol-induced fatty liver disease (AFLD).
• Abstinence from alcohol can resolve steatosis, but the underlying hepatocellular mechanisms require elucidation.
• Understanding these resolution mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the specific catabolic events and hepatocellular changes that occur during the resolution of AFLD following ethanol withdrawal.
• To test the hypothesis that ethanol withdrawal reactivates lipid catabolic processes, restoring lipostasis.
• To identify key molecular players involved in the reversal of fatty liver and injury.

Main Methods:

• Male Wistar rats were fed control or ethanol liquid diets for 6 weeks.
• Ethanol-fed rats were subsequently refed a control diet for 7 days to study withdrawal effects.
• Quantification of liver triglycerides, lipid peroxides, fatty acid metabolism markers, lipophagy, and autophagy, including transcription factor EB (TFEB) and peroxisome proliferator-activated receptor-α (PPAR-α).

Main Results:

• Ethanol-fed rats exhibited increased hepatic triglycerides, lipid peroxides, and serum free fatty acids (FFA), with altered fatty acid transporters (FATPs) and reduced PPAR-α and nuclear TFEB.
• Ethanol withdrawal led to decreased hepatic triglycerides and lipid peroxides.
• Withdrawal normalized serum FFA and FATPs, increased PPAR-α, and restored nuclear TFEB, enhancing hepatic lipophagy and autophagy.

Conclusions:

• Ethanol withdrawal reverses alcohol-induced fatty liver by reactivating lipid catabolic processes.
• Restoration of peroxisome proliferator-activated receptor-α (PPAR-α) and transcription factor EB (TFEB) are key events.
• Reactivation of autophagy and lysosome function via TFEB contributes significantly to the resolution of AFLD and associated liver injury.